Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > First I've heard of it....

<< Previous

Bullboard Posts

Next >>

Post by 2021Gambleon Mar 30, 2023 8:37pm

250 Views

Post# 35370771

First I've heard of it....

And the Jan 23rd update on the PP distribution shows that even then that it would have been a planned shortfall as only $60k was allocated to F.C.

There has been ample 'update' news releases where this could have been buried, but I haven't seen it ... Wonder whether it's buried in a past md&a,but I don't recall reading 'bout this previous to this

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant